drugset / Trial / NCT00868959
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
NaSingle-groupOpen-labelTreatment
Summary
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression
Timeline
- Start
- 2009-04
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 20 mg | — |
| Subject | Lurasidone | Small molecule | 120 mg | — |